MXPA02007039A - Ocular growth and nicotinic antagonists. - Google Patents

Ocular growth and nicotinic antagonists.

Info

Publication number: MXPA02007039A
Authority: MX; Mexico
Prior art keywords: nicotinic antagonists; ocular growth; ocular; growth; nicotinic
Prior art date: 2000-01-18

Application number

MXPA02007039A

Other languages

Spanish (es)

Inventor

Richard A Stone

Original Assignee

Univ Pennsylvania

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-01-18

Filing date

2001-01-18

Publication date

2003-09-25

2001-01-18 Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania

2003-09-25 Publication of MXPA02007039A publication Critical patent/MXPA02007039A/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4747—Quinolines; Isoquinolines spiro-condensed
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Ophthalmology & Optometry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

MXPA02007039A 2000-01-18 2001-01-18 Ocular growth and nicotinic antagonists. MXPA02007039A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US17687500P	2000-01-18	2000-01-18
PCT/US2001/001692 WO2001052832A1 (en)	2000-01-18	2001-01-18	Ocular growth and nicotinic antagonists

Publications (1)

Publication Number	Publication Date
MXPA02007039A true MXPA02007039A (en)	2003-09-25

Family

ID=22646232

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MXPA02007039A MXPA02007039A (en)	2000-01-18	2001-01-18	Ocular growth and nicotinic antagonists.

Country Status (10)

Country	Link
EP (1)	EP1272170A1 (en)
JP (1)	JP2003520228A (en)
KR (1)	KR20020081260A (en)
CN (1)	CN1418095A (en)
AU (1)	AU775516B2 (en)
CA (1)	CA2400803A1 (en)
HK (1)	HK1052464A1 (en)
MX (1)	MXPA02007039A (en)
RU (1)	RU2002120485A (en)
WO (1)	WO2001052832A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1978926A2 (en) *	2005-12-19	2008-10-15	Comentis, Inc.	Topical mecamylamine formulations for ocular administration and uses thereof
FI20075498A7 (en)	2007-06-29	2008-12-30	Eero Castren	Method for treating amblyopia with antidepressants
FI3593817T3 (en)	2017-03-06	2025-02-05	Tsubota Lab Inc	Composition for use in the prevention or suppression of myopia
US12459965B2 (en)	2017-10-09	2025-11-04	Compass Pathfinder Limited	Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
GB2571696B (en)	2017-10-09	2020-05-27	Compass Pathways Ltd	Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
CN113993523A (en)	2019-04-17	2022-01-28	指南针探路者有限公司	Treatment of depression and other various disorders with siloxibin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0478694B1 (en) *	1989-06-21	1997-01-15	The Trustees Of The University Of Pennsylvania	use of pirenzepine, telenzepine oder O-methoxy -sila-hexocyclium in the manufacture of a medicament for the TREATMENT AND CONTROL OF OCULAR DEVELOPMENT
AU5312198A (en) *	1997-01-06	1998-08-03	Klaus Trier Aps	Screening method

2001
- 2001-01-18 WO PCT/US2001/001692 patent/WO2001052832A1/en not_active Ceased
- 2001-01-18 AU AU30969/01A patent/AU775516B2/en not_active Ceased
- 2001-01-18 RU RU2002120485/15A patent/RU2002120485A/en not_active Application Discontinuation
- 2001-01-18 HK HK03104752.7A patent/HK1052464A1/en unknown
- 2001-01-18 MX MXPA02007039A patent/MXPA02007039A/en active IP Right Grant
- 2001-01-18 EP EP01903112A patent/EP1272170A1/en not_active Withdrawn
- 2001-01-18 CN CN01806785A patent/CN1418095A/en active Pending
- 2001-01-18 KR KR1020027009160A patent/KR20020081260A/en not_active Withdrawn
- 2001-01-18 JP JP2001552880A patent/JP2003520228A/en not_active Abandoned
- 2001-01-18 CA CA002400803A patent/CA2400803A1/en not_active Abandoned

Also Published As

Publication number	Publication date
HK1052464A1 (en)	2003-09-19
AU3096901A (en)	2001-07-31
EP1272170A1 (en)	2003-01-08
AU775516B2 (en)	2004-08-05
KR20020081260A (en)	2002-10-26
RU2002120485A (en)	2004-04-10
CA2400803A1 (en)	2001-07-26
CN1418095A (en)	2003-05-14
JP2003520228A (en)	2003-07-02
WO2001052832A1 (en)	2001-07-26

Publication	Publication Date	Title
AU9684401A (en)	2002-04-22	Hedgehog antagonists, methods and uses related thereto
DE60141136D1 (en)	2010-03-11	Selektive photocoagulation
MXPA03001928A (en)	2003-06-19	Quinoline and quinazoline derivatives.
HUP0301243A3 (en)	2009-01-28	Herbicidal substituted pyridine-ketones, preparation and use thereof
ZA200205557B (en)	2003-07-11	4-Aminopicolinates and their use as herbicides.
ZA200109189B (en)	2002-08-28	Artificial stone and formation thereof.
PL365787A1 (en)	2005-01-10	Heterocyclic compounds, their production and use
AU2001288720A1 (en)	2002-03-22	Implantable article
MXPA03000738A (en)	2003-06-04	Ghrelin antagonists.
GB2361235B (en)	2002-06-12	2,2,6,6 Diethyl-dimethyl-1-alkoxy-piperidine compounds and their corresponding 1-oxides
MXPA03004932A (en)	2003-09-10	Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors.
HUP0302772A3 (en)	2007-03-28	Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one and use thereof for inhibiting hormone-sensitive lipase
AU2002235780A1 (en)	2002-09-05	Flavour concentrates
AU2001234741A1 (en)	2001-08-14	Integrin antagonists
AU146195S (en)	2001-12-06	An eyeshield
GB0015562D0 (en)	2000-08-16	Heterocycles
NZ513917A (en)	2001-09-28	1-aryl-1,3,5-triazine-4-thione-2,6-diones, production thereof and use thereof as herbicides
AU2001227066A1 (en)	2001-07-31	Herbicidal microemulsion
AU2001266939A1 (en)	2002-01-30	Biocidal polyamides and methods
MXPA02007039A (en)	2003-09-25	Ocular growth and nicotinic antagonists.
AU7635401A (en)	2001-12-24	Hetaryl-substituted heterocycles
MXPA03001951A (en)	2003-10-15	Substituted fused pyrroleimines and pyrazoleimines.
IL154382A0 (en)	2003-09-17	Improved insecticidal bacteria, and methods for making and using them
AU2001294776A1 (en)	2002-04-08	Lactone integrin antagonists
GB0003746D0 (en)	2000-04-05	Implements and their manufacture

Legal Events

Date	Code	Title	Description
2004-12-31	GB	Transfer or rights
2005-12-07	FG	Grant or registration